Bottom line
DLHIX vs RYHIX: the short answer
DLHIX (Nomura Healthcare Fund) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 43% by weight.
DLHIX is cheaper at 0.96% vs 1.38% — a difference of $42 a year per $10,000 invested.
Over five years, DLHIX returned +7.8% a year vs +5.1% for RYHIX.
Updated Nov 19, 2026
DLHIX vs RYHIX side by side
| DLHIX | RYHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Voya | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.96% | 1.38% |
| Annual cost per $10k | $96 | $138 |
| 10-yr cost on $10k (prospectus) | $1,232 | $1,709 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +22.4% | +14.4% |
| 5-yr return (annualized) | +7.8% | +5.1% |
| 10-yr return (annualized) | +10.4% | +7.9% |
| Best quarter | — | +18.7% |
| Worst quarter | — | −14.4% |
| Net assets (fund) | $750.2M | $19.4M |
| Number of holdings | 108 | 135 |
| Portfolio turnover | 4% | 244% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of DLHIX's top 25 holdings also appear in RYHIX's top 25.
| Holding | DLHIX | RYHIX |
|---|---|---|
| Abbvie Inc | 4.19% | 2.52% |
| Eli Lilly & Company | 4.16% | 3.63% |
| Regeneron Pharmaceuticals Inc | 3.91% | 0.90% |
| Unitedhealth Group Inc | 3.88% | 2.22% |
| Pfizer Inc | 3.84% | 1.25% |
| Merck & Company Inc | 3.68% | 2.04% |
| Gilead Sciences Inc | 3.54% | 1.39% |
| Elevance Health Inc | 3.25% | 1.02% |
| Amgen Inc | 2.27% | 1.56% |
| Vertex Pharmaceuticals Inc | 1.66% | 1.34% |
| Boston Scientific Corp | 1.42% | 0.86% |
Source: SEC Form N-PORT
DLHIX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between DLHIX and RYHIX?
DLHIX (Nomura Healthcare Fund) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 43% by weight. DLHIX is cheaper at 0.96% vs 1.38% — a difference of $42 a year per $10,000 invested.
Which is cheaper, DLHIX or RYHIX?
DLHIX has the lower expense ratio (0.96%).
Should I own both DLHIX and RYHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.